Status:
COMPLETED
Vardenafil Treatment Of Erectile Dysfunction In Depressive And Non-Depressive Men
Lead Sponsor:
Bayer
Conditions:
Erectile Dysfunction
Eligibility:
MALE
18+ years
Brief Summary
The primary aim of this open, uncontrolled, prospective, non-interventional post-marketing surveillance study is to obtain data on safety and efficacy of Levitra in routine treatment of erectile dysfu...
Eligibility Criteria
Inclusion
- Age over 18
- Erectile dysfunction untreated or ineffectively treated with other than vardenafil PDE5 inhibitors
Exclusion
- Treatment with nitrates
- Allergy to vardenafil or other tablets ingredients
- Treatment with CYP3A4 inhibitors (e.g. indinavir, ritonavir, ketoconazole, itraconazole, erythromycin)
- Cardiovascular status excluding any sexual activity
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
2471 Patients enrolled
Trial Details
Trial ID
NCT00470873
Start Date
January 1 2007
End Date
February 1 2008
Last Update
December 2 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Poland